POC diagnostics company Epocal gets $31mm via Series C
Canadian diagnostics firm Epocal grossed $31mm through its Series C financing led by new investor Highland Capital Management, which was joined by other backers including Genesys Capital Partners, a returning shareholder. A member of Highland takes a seat on the company's board. Aquilo Partners acted as the placement agent.
- In Vitro Diagnostics
- Medical Devices
In Vitro Diagnostics
- Chemistry, Immunoassay
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com